| abstract |
Formula I, which is an antagonist of the CGRP receptor and useful for the treatment or prevention of diseases involving CGRP such as migraine: Wherein the variables A 1 , A 2 , B, m, n, J, R 4 , G 1 , G 2 , G 3 and Y are as described herein. The present invention also relates to pharmaceutical compositions containing these compounds and the use of these compounds and compositions in the prevention or treatment of the aforementioned diseases in which CGRP is involved. |